Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, until what date the recommendations in the NICE COVID-19 rapid guideline: severe asthma will remain in place.
The National Institute for Health and Care Excellence is unable to confirm a date on which the recommendations in the COVID-19 rapid guideline on severe asthma [NG166] will cease to be in place at this time.
COVID-19 rapid guidelines, and their individual recommendations, will be kept under review and may be considered for withdrawal:
- If the guideline or recommendations are no longer needed or become redundant/obsolete because service delivery has changed (e.g. normal services have resumed), or the recommendations are likely to have limited relevance for the service beyond the timeframe of the current crisis;
- If there are safety issues, for example, the recommendations may harm patients, service users or health and social care practitioners; and
- To remove duplication of recommendations if guideline content or certain recommendations within the COVID-19 suite are merged.